Next-generation Atrial Fibrillation Ablation: Clinical Performance of Pulsed-field Ablation and Very High-power Short-duration Radiofrequency

Overview

Journal J Interv Card Electrophysiol

Publisher Springer

Date 2024 Jul 12

PMID 38997610

Authors

Nibras Soubh

Judith Gronwald

Helge Haarmann

Eva Rasenack

Philipp Bengel

Simon Schlogl

Gerd Hasenfuss

Markus Zabel

Leonard Bergau

Affiliations

Soon will be listed here.

Abstract

Introduction: Pulsed-field energy (PFA) and very high-power short-duration radiofrequency (vHPSD-RF) are two novel ablation methods for pulmonary vein isolation (PVI). Both PFA and vHPSD-RF show promise for improving efficacy, safety, and reducing procedure durations. However, direct comparisons between these two techniques are scarce.

Methods And Results: Retrospective analysis of 82 patients with symptomatic AF. Of these, 52 patients received PFA and 30 received vHPSD-RF (90 W, 4 s) as index procedure. At the 6-month follow-up, AF recurrence occurred in 4 patients following PFA and 5 patients following vHPSD-RF (p-value = 0.138). Significant improvements in the EHRA and NYHA stages were evident in both PFA (p < 0.001 and p = 0.047, respectively) and vHPSD-RF groups (p = 0.007 and p = 0.012, respectively). The total procedure duration and the left atrial dwell time were significantly shorter in the PFA group (64 ± 19 min vs. 99 ± 32 min, p < 0.001 and 41 ± 12 min vs. 62 ± 29 min, p < 0.001, respectively). The fluoroscopy time and dose area product were significantly higher in PFA (14 ± 6 vs. 9 ± 5 min, p < 0.001 and 14 ± 9 vs. 11 ± 9 Gy cm, p = 0.046, respectively). One patient in the vHPSD-RF group suffered a stroke, not directly linked to the procedure (0 vs. 1 major complication, p = 0.366).

Conclusion: Based on this retrospective single-center study, PFA and vHPSD-RF were associated with similar effectiveness and safety profiles. PFA was linked to shorter procedure times and higher radiation exposure compared to vHPSD-RF.

References

Bourier F, Sommer P . The Shorter, the Better?: Short Duration Ablation, Catheter Stability, and Lesion Durability. JACC Clin Electrophysiol. 2020; 6(8):986-988. DOI: 10.1016/j.jacep.2020.05.001. View

Koruth J, Kuroki K, Iwasawa J, Enomoto Y, Viswanathan R, Brose R . Preclinical Evaluation of Pulsed Field Ablation: Electrophysiological and Histological Assessment of Thoracic Vein Isolation. Circ Arrhythm Electrophysiol. 2019; 12(12):e007781. PMC: 6924932. DOI: 10.1161/CIRCEP.119.007781. View

Bourier F, Duchateau J, Vlachos K, Lam A, Martin C, Takigawa M . High-power short-duration versus standard radiofrequency ablation: Insights on lesion metrics. J Cardiovasc Electrophysiol. 2018; 29(11):1570-1575. DOI: 10.1111/jce.13724. View

Wormann J, Schipper J, Luker J, van den Bruck J, Filipovic K, Erlhofer S . Comparison of pulsed-field ablation versus very high power short duration-ablation for pulmonary vein isolation. J Cardiovasc Electrophysiol. 2023; 34(12):2417-2424. DOI: 10.1111/jce.16101. View

Tilz R, Sano M, Vogler J, Fink T, Saraei R, Sciacca V . Very high-power short-duration temperature-controlled ablation versus conventional power-controlled ablation for pulmonary vein isolation: The fast and furious - AF study. Int J Cardiol Heart Vasc. 2021; 35:100847. PMC: 8333145. DOI: 10.1016/j.ijcha.2021.100847. View

Reddy V, Neuzil P, Koruth J, Petru J, Funosako M, Cochet H . Pulsed Field Ablation for Pulmonary Vein Isolation in Atrial Fibrillation. J Am Coll Cardiol. 2019; 74(3):315-326. DOI: 10.1016/j.jacc.2019.04.021. View

Njoku A, Kannabhiran M, Arora R, Reddy P, Gopinathannair R, Lakkireddy D . Left atrial volume predicts atrial fibrillation recurrence after radiofrequency ablation: a meta-analysis. Europace. 2017; 20(1):33-42. DOI: 10.1093/europace/eux013. View

Aldaas O, Malladi C, Han F, Hoffmayer K, Krummen D, Ho G . Pulsed field ablation versus thermal energy ablation for atrial fibrillation: a systematic review and meta-analysis of procedural efficiency, safety, and efficacy. J Interv Card Electrophysiol. 2023; 67(3):639-648. PMC: 11016003. DOI: 10.1007/s10840-023-01660-3. View

Turagam M, Neuzil P, Schmidt B, Reichlin T, Neven K, Metzner A . Safety and Effectiveness of Pulsed Field Ablation to Treat Atrial Fibrillation: One-Year Outcomes From the MANIFEST-PF Registry. Circulation. 2023; 148(1):35-46. DOI: 10.1161/CIRCULATIONAHA.123.064959. View

10.

Badertscher P, Weidlich S, Knecht S, Stauffer N, Krisai P, Voellmin G . Efficacy and safety of pulmonary vein isolation with pulsed field ablation vs. novel cryoballoon ablation system for atrial fibrillation. Europace. 2023; 25(12). PMC: 10751845. DOI: 10.1093/europace/euad329. View

11.

Urbanek L, Bordignon S, Schaack D, Chen S, Tohoku S, Efe T . Pulsed Field Versus Cryoballoon Pulmonary Vein Isolation for Atrial Fibrillation: Efficacy, Safety, and Long-Term Follow-Up in a 400-Patient Cohort. Circ Arrhythm Electrophysiol. 2023; 16(7):389-398. DOI: 10.1161/CIRCEP.123.011920. View

12.

Perez J, dAngelo R, Gonzalez-Suarez A, Nakagawa H, Berjano E, dAvila A . Low-energy (360 J) radiofrequency catheter ablation using moderate power - short duration: proof of concept based on in silico modeling. J Interv Card Electrophysiol. 2022; 66(5):1085-1093. DOI: 10.1007/s10840-022-01292-z. View

13.

Ekanem E, Reddy V, Schmidt B, Reichlin T, Neven K, Metzner A . Multi-national survey on the methods, efficacy, and safety on the post-approval clinical use of pulsed field ablation (MANIFEST-PF). Europace. 2022; 24(8):1256-1266. PMC: 9435639. DOI: 10.1093/europace/euac050. View

14.

Reddy V, Gerstenfeld E, Natale A, Whang W, Cuoco F, Patel C . Pulsed Field or Conventional Thermal Ablation for Paroxysmal Atrial Fibrillation. N Engl J Med. 2023; 389(18):1660-1671. DOI: 10.1056/NEJMoa2307291. View

15.

Hindricks G, Potpara T, Dagres N, Arbelo E, Bax J, Blomstrom-Lundqvist C . 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the.... Eur Heart J. 2020; 42(5):373-498. DOI: 10.1093/eurheartj/ehaa612. View

16.

Reddy V, Grimaldi M, De Potter T, Vijgen J, Bulava A, Duytschaever M . Pulmonary Vein Isolation With Very High Power, Short Duration, Temperature-Controlled Lesions: The QDOT-FAST Trial. JACC Clin Electrophysiol. 2019; 5(7):778-786. DOI: 10.1016/j.jacep.2019.04.009. View

17.

Heeger C, Sano M, Popescu S, Subin B, Feher M, Phan H . Very high-power short-duration ablation for pulmonary vein isolation utilizing a very-close protocol-the FAST AND FURIOUS PVI study. Europace. 2022; 25(3):880-888. PMC: 10062369. DOI: 10.1093/europace/euac243. View

18.

Tilz R, Schmidt V, Purerfellner H, Maury P, Chun K, Martinek M . A worldwide survey on incidence, management, and prognosis of oesophageal fistula formation following atrial fibrillation catheter ablation: the POTTER-AF study. Eur Heart J. 2023; 44(27):2458-2469. PMC: 10344651. DOI: 10.1093/eurheartj/ehad250. View

19.

Reddy V, Dukkipati S, Neuzil P, Anic A, Petru J, Funasako M . Pulsed Field Ablation of Paroxysmal Atrial Fibrillation: 1-Year Outcomes of IMPULSE, PEFCAT, and PEFCAT II. JACC Clin Electrophysiol. 2021; 7(5):614-627. DOI: 10.1016/j.jacep.2021.02.014. View

20.

Calkins H, Hindricks G, Cappato R, Kim Y, Saad E, Aguinaga L . 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Europace. 2017; 20(1):e1-e160. PMC: 5834122. DOI: 10.1093/europace/eux274. View